Actively Recruiting
Epidemiology, Treatment Patterns, and Healthcare Resource Use in Children Under 18 With Inflammatory Bowel Diseases in Korea: A Claims Database Study
Led by Janssen Korea, Ltd., Korea · Updated on 2026-06-05
8000
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand inflammatory bowel diseases (IBD), specifically Crohn's disease (CD) and ulcerative colitis (UC), in children under 18 years old in Korea. It focuses on the number of children diagnosed each year, how this varies by age group, their treatment over time, and the use and cost of healthcare services related to these conditions. CD and UC cause long-term inflammation and ulcers in the intestines. Participants include children who have been newly or previously diagnosed with CD or UC. The study analyzes data from health insurance records to examine epidemiology, demographics, clinical features, healthcare use, and treatment patterns. Only newly diagnosed children will be included for detailed treatment pattern and incidence analysis. All data is de-identified and collected from routine clinical practice records. Children's data will be reviewed for diagnosis codes, medication use, hospital visits, surgeries, and medical costs over several years. Researchers will measure annual incidence and prevalence rates, treatment sequences, hospitalizations, emergency visits, surgeries, and healthcare costs from 2012 to 2023, with follow-up up to 13 years. This observational study uses existing data without direct intervention or additional procedures.
CONDITIONS
Brief Title
A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants under 18 years old
- Diagnosed with Crohn's disease or ulcerative colitis using ICD-10 or rare disease registration codes
- Have at least two outpatient or one inpatient diagnosis codes for the same disease type during the study period
- Received at least one prescription for pediatric IBD-related medication during the study period
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Data is collected from existing health records without in-person visits
Duration - Up to 13 years
Participants' health data is observed over time to analyze epidemiology, treatment patterns, healthcare resource use, and associated costs.
No in-person visits; data collected from routine healthcare records
Trial Site Locations
Total: 1 location
1
Sungkyunkwan University Research and Business Foundation
Suwon, South Korea, 16419
Actively Recruiting
Research Team
S
Study Contact
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here